Trials / Completed
CompletedNCT04859933
AV Node Isolation in Atrial Fibrillation vs. Modulation by "Pace and Ablate" Strategy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Heart and Diabetes Center North-Rhine Westfalia · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
AV-node ablation (AVNA) is a common therapy option for rate control strategy of permanent atrial fibrillation with numerous side effects. The investigators hypothesised that an isolation of the AV node is concomitant with less occurrence of new bundle brunch blocks, more frequent preservation and higher rate of escape rhythm compared to AVNA. This retrospective study includes 20 patients being treated with AV-node isolation (AVNI) and 40 historical AVNA-controls. Among others these two methods were compared regarding escape rhythm, delta QRS, procedure time, ablation points, fluoroscopy time and total dose area product (DAP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | AV-node isolation | Abaltion performed in the right atrium isolating the AV-node from the atrium |
| PROCEDURE | AV-node ablation | Right sided ablation of the AV-node |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
- First posted
- 2021-04-26
- Last updated
- 2022-08-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04859933. Inclusion in this directory is not an endorsement.